Evidence map›Paper›PMID 26367193›Full record

ArticleCOPD2015

Targeting Persons With or At High Risk for Chronic Obstructive Pulmonary Disease by State-based Surveillance.

Roy A Pleasants, Khosrow Heidari, Anne G Wheaton, Jill A Ohar, Charlie Strange, Janet B Croft, Winston Liao, David M Mannino, Monica Kraft

Open access · greenAbstract read
In one paragraph

Article in COPD, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Gender and asthma-chronic obstructive pulmonary disease overlap syndrome.The Journal of asthma : official journal of the Association for the Care of Asthma · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 8 institutions in 1 country.

Roy A Pleasantsa Division of Pulmonary, Allergy, and Critical Care Medicine, Duke University School of Medicine, and Durham VA Medical Center , Durham , North Carolina , USA.
Khosrow Heidarib Chronic Disease Epidemiology Office, South Carolina Department of Health and Environmental Control , Columbia , South Carolina , USA.
Anne G Wheatonc Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention , Atlanta , Georgia , USA.
Jill A Ohard Section on Pulmonary, Critical Care, Allergy & Immunologic Disease, Wake Forest University School of Medicine , Winston-Salem , North Carolina , USA.
Charlie Strangee Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Medical University of South Carolina , Charleston , South Carolina , USA.
Janet B Croftf Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention , Atlanta , Georgia.
Winston Liaog Consultant, North Carolina COPD Taskforce , Cary, North Carolina , USA.
David M Manninoh Division of Pulmonary, Critical Care, and Sleep Medicine, Pulmonary Epidemiology Research Laboratory, University of Kentucky , Lexington , Kentucky , USA.
Monica Krafti Department of Medicine, University of Arizona College of Medicine , Tucson , Arizona , USA.
Centers for Disease Control and Prevention · US3C Institute · USDuke University · USMedical University of South Carolina · USSouth Carolina Department of Health and Environmental Control · USUniversity of Arizona · USUniversity of Kentucky · USWake Forest University · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

unlabelledThe Behavioral Risk Factor Surveillance System (BRFSS) survey is used to estimate chronic obstructive pulmonary disease (COPD) prevalence and could be expanded to describe respiratory symptoms in the general population and to characterize persons with or at high risk for the disease. Tobacco duration and respiratory symptom questions were added to the 2012 South Carolina BRFSS. Data concerning sociodemographics, chronic illnesses, health behaviors, and respiratory symptoms were collected in 9438 adults ≥ 35 years-old. Respondents were categorized as having COPD, high risk, or low risk for the disease. High risk was defined as no self-reported COPD, ≥ 10 years' tobacco use, and ≥ 1 respiratory symptom (frequent productive cough or shortness of breath (SOB), or breathing problems affecting activities). Prevalence of self-reported and high-risk COPD were 9.1% and 8.0%, respectively. Overall, 17.3%, 10.6%, and 5.2% of all respondents reported activities limited by breathing problems, frequent productive cough, and frequent SOB, respectively. The high-risk group was more likely than the COPD group to report a productive cough and breathing problems limiting activities as well as being current smokers, male, and African-American. Health impairment was more severe in the COPD than the high-risk group, and both were worse than the low-risk group.

conclusionsPersons at high risk for COPD share many, but not all, of the characteristics of persons diagnosed with the disease. Additional questions addressing smoking duration and respiratory symptoms in the BRFSS identifies groups at high risk for having or developing COPD who may benefit from smoking cessation and case-finding interventions.

Indexed as

AdultAgedBehavioral Risk Factor Surveillance SystemFemaleHealth BehaviorHumansMaleMiddle AgedPrevalencePulmonary Disease, Chronic ObstructiveRisk AssessmentSelf ReportSmokingSocioeconomic FactorsUnited Stateschronic obstructive pulmonary diseasepopulation surveillancerespiratory symptomstobacco exposureunderdiagnosis

Identifiers

PMID26367193
PMCPMC4674427
OpenAlexW1774258656

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.